STEX underwent a massive corporate transformation with assets exploding from $842K to $187.5M while net losses deepened catastrophically from -$10.3M to -$462.8M, accompanied by a complete corporate identity change from BioSig Technologies to Streamex Corp.
This represents a fundamental business transformation rather than organic growth, likely involving a major acquisition, merger, or restructuring that completely changed the company's scale and operations. The extreme deterioration in net losses despite the massive asset increase suggests either significant one-time charges, integration costs, or that the acquired operations are highly unprofitable, creating substantial uncertainty about the combined entity's viability.
The company experienced an extraordinary transformation with total assets growing over 22,000% to $187.5M and cash increasing 100-fold to $20.3M, while stockholders' equity swung from negative $1.5M to positive $133.2M, indicating a major capital injection or acquisition. However, net losses exploded nearly 44-fold to -$462.8M and operating losses increased over 4-fold to -$71.1M, while operating cash flow deteriorated further to -$10.4M. This financial profile suggests a transformative corporate event that dramatically expanded the business scale but at the cost of massive losses that dwarf the previous year's already-unprofitable operations.
Asset base grew 22173.5% — expansion through organic growth, acquisitions, or capital deployment.
Current assets grew 20799.7% — improving short-term liquidity or inventory/receivables build.
Cash position surged 10050% — strong cash generation or capital raise providing significant financial cushion.
Equity base grew 8726.4% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Net income declined 4379.9% — review whether driven by operations, interest costs, or non-recurring items.
Liabilities grew 2294.7% — significant increase in debt or obligations, assess impact on financial flexibility.
Current liabilities surged 1790.2% — significant near-term obligations; verify ability to meet short-term debt.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Receivables surged 354.2% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.
Operating cash flow fell 119.4% — earnings quality concerns; investigate working capital changes and non-cash items.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →